• SPX
  • $5,713.64
  • 1.7 %
  • $95.38
  • DJI
  • $42,025.19
  • 1.26 %
  • $522.09
  • N225
  • $37,903.78
  • 2.01 %
  • $748.52
  • FTSE
  • $8,328.72
  • 0.91 %
  • $75.04
  • IXIC
  • $18,013.98
  • 2.51 %
  • $440.68
NuVasive, Inc. (NUVA) Latest News

NuVasive, Inc. (NUVA) Latest News

NASDAQ Currency in USD Disclaimer

Stock Price
Day's range
$39.51
Day's range
$40.96

Latest News of NUVA

Nuvalent, Inc. (NUVL) Stock Price, News, Quote & History - Yahoo Finance

By Yahoo! Finance | 3 days ago

Nuvalent, a biopharmaceutical company, has initiated a public offering of $350 million of its Class A common stock to support its cancer-focused kinase therapies. The completion of the offering is sub...

Nuvalent Shares Gain on Cancer Drug Trial Updates

By MarketWatch | 3 days ago

Nuvalent's shares surged 20% in premarket trading after positive updates on its cancer drug programs. Phase 1 trials showed promising results for zidesamtinib and NVL-655, with Phase 2 trials progress...

Nuvalent, Inc. (NUVL): Among Hedge Funds' Top Biotech Stock Picks

By Yahoo! Finance | 5 days ago

The article discusses the risks and potential rewards of investing in biotechnology stocks, focusing on Nuvalent, Inc. (NASDAQ:NUVL). It highlights the importance of deep analysis, diversification, an...

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.